thiourea and Chlamydia-Infections

thiourea has been researched along with Chlamydia-Infections* in 2 studies

Other Studies

2 other study(ies) available for thiourea and Chlamydia-Infections

ArticleYear
Small Molecule Inhibition of Rab7 Impairs B Cell Class Switching and Plasma Cell Survival To Dampen the Autoantibody Response in Murine Lupus.
    Journal of immunology (Baltimore, Md. : 1950), 2016, 11-15, Volume: 197, Issue:10

    Topics: Animals; Autoantibodies; B-Lymphocytes; Cell Proliferation; Cell Survival; Chlamydia Infections; Female; Gene Expression Regulation; Heterocyclic Compounds, 2-Ring; Immunoglobulin Class Switching; Immunoglobulin G; Lupus Erythematosus, Systemic; Lymphocyte Activation; Mice; Mice, Inbred MRL lpr; NF-kappa B; Plasma Cells; rab GTP-Binding Proteins; rab7 GTP-Binding Proteins; T-Lymphocytes; Thiourea; Up-Regulation

2016
The broad-spectrum antiviral compound ST-669 restricts chlamydial inclusion development and bacterial growth and localizes to host cell lipid droplets within treated cells.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:7

    Novel broad-spectrum antimicrobials are a critical component of a strategy for combating antibiotic-resistant pathogens. In this study, we explored the activity of the broad-spectrum antiviral compound ST-669 for activity against different intracellular bacteria and began a characterization of its mechanism of antimicrobial action. ST-669 inhibits the growth of three different species of chlamydia and the intracellular bacterium Coxiella burnetii in Vero and HeLa cells but not in McCoy (murine) cells. The antichlamydial and anti-C. burnetii activity spectrum was consistent with those observed for tested viruses, suggesting a common mechanism of action. Cycloheximide treatment in the presence of ST-669 abrogated the inhibitory effect, demonstrating that eukaryotic protein synthesis is required for tested activity. Immunofluorescence microscopy demonstrated that different chlamydiae grow atypically in the presence of ST-669, in a manner that suggests the compound affects inclusion formation and organization. Microscopic analysis of cells treated with a fluorescent derivative of ST-669 demonstrated that the compound localized to host cell lipid droplets but not to other organelles or the host cytosol. These results demonstrate that ST-669 affects intracellular growth in a host-cell-dependent manner and interrupts proper development of chlamydial inclusions, possibly through a lipid droplet-dependent process.

    Topics: Animals; Antiviral Agents; Cells, Cultured; Chlamydia; Chlamydia Infections; Coxiella burnetii; Genome, Bacterial; Humans; Inclusion Bodies; Lipids; Mice; Thiourea

2014